Bleakley Financial Group LLC Sells 594 Shares of Unum Group (NYSE:UNM)

Bleakley Financial Group LLC reduced its stake in shares of Unum Group (NYSE:UNM) by 10.0% during the 4th quarter, HoldingsChannel reports. The fund owned 5,362 shares of the financial services provider’s stock after selling 594 shares during the period. Bleakley Financial Group LLC’s holdings in Unum Group were worth $242,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in UNM. Silver Oak Securities Incorporated bought a new stake in Unum Group during the third quarter worth approximately $25,000. Contravisory Investment Management Inc. bought a new stake in Unum Group during the fourth quarter worth approximately $25,000. Bangor Savings Bank increased its stake in Unum Group by 100.0% during the third quarter. Bangor Savings Bank now owns 664 shares of the financial services provider’s stock worth $33,000 after acquiring an additional 332 shares during the last quarter. Neo Ivy Capital Management bought a new stake in Unum Group during the third quarter worth approximately $36,000. Finally, Arlington Trust Co LLC bought a new stake in Unum Group during the third quarter worth approximately $38,000. 86.57% of the stock is owned by institutional investors.

Analyst Ratings Changes

UNM has been the topic of several analyst reports. StockNews.com raised Unum Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 31st. JPMorgan Chase & Co. boosted their target price on Unum Group from $56.00 to $58.00 and gave the company an “overweight” rating in a research report on Tuesday, April 2nd. Wells Fargo & Company boosted their target price on Unum Group from $64.00 to $66.00 and gave the company an “overweight” rating in a research report on Thursday, April 11th. Morgan Stanley boosted their target price on Unum Group from $50.00 to $52.00 and gave the company an “equal weight” rating in a research report on Monday. Finally, The Goldman Sachs Group boosted their target price on Unum Group from $47.00 to $52.00 and gave the company a “neutral” rating in a research report on Wednesday, January 31st. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $56.38.

Unum Group Stock Down 0.7 %

Shares of NYSE UNM opened at $49.95 on Tuesday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.27 and a current ratio of 0.27. The firm has a market capitalization of $9.59 billion, a price-to-earnings ratio of 7.70, a PEG ratio of 1.01 and a beta of 0.87. The stock has a 50 day moving average price of $50.77 and a 200 day moving average price of $47.53. Unum Group has a 52-week low of $39.71 and a 52-week high of $54.57.

Unum Group (NYSE:UNM) last announced its quarterly earnings results on Tuesday, January 30th. The financial services provider reported $1.79 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.86 by ($0.07). The firm had revenue of $3.15 billion during the quarter, compared to analysts’ expectations of $3.14 billion. Unum Group had a net margin of 10.36% and a return on equity of 16.03%. The firm’s revenue for the quarter was up 4.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.43 EPS. Sell-side analysts expect that Unum Group will post 8.18 earnings per share for the current year.

Unum Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 17th. Investors of record on Friday, April 26th will be issued a $0.365 dividend. The ex-dividend date is Thursday, April 25th. This represents a $1.46 dividend on an annualized basis and a dividend yield of 2.92%. Unum Group’s payout ratio is 22.50%.

Insider Activity at Unum Group

In related news, EVP Elizabeth Claire Ahmed sold 5,000 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $50.00, for a total value of $250,000.00. Following the completion of the transaction, the executive vice president now owns 55,450 shares of the company’s stock, valued at $2,772,500. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CFO Steven Andrew Zabel sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $51.06, for a total value of $510,600.00. Following the completion of the transaction, the chief financial officer now owns 122,246 shares of the company’s stock, valued at $6,241,880.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Elizabeth Claire Ahmed sold 5,000 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $50.00, for a total transaction of $250,000.00. Following the completion of the transaction, the executive vice president now directly owns 55,450 shares of the company’s stock, valued at approximately $2,772,500. The disclosure for this sale can be found here. Over the last quarter, insiders sold 81,000 shares of company stock worth $4,018,100. Company insiders own 0.77% of the company’s stock.

Unum Group Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.